AMZN
Amazon.com, Inc.
AMZN has the edge over ROST overall, supported by stronger valuation and stronger modeled upside.
ROST
Ross Stores, Inc.
ROST has slightly lower modeled downside risk, despite its lower overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ROST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
ROST's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ROST in the historical PE scenario, which offers more potential upside but is not a forecast.
ROST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $178 | -25% |
| Fair | 25x | $210 | -12% |
| Forward | 27x | $237 | — |
| Current | 29x | $237 | — |
| Expensive | 35x | $286 | +21% |
Historical ranges are pointers, not guarantees.
ROST's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ROST Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
ROST has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ROST on earnings, with stronger typical year-over-year growth.
ROST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.78 | +6.3% |
| Q3 2026 | $8.26 | +31% |
| Q2 2026 | $7.16 | +13% |
| Q1 2026 | $6.61 | +4.6% |
| Q4 2025 | $6.40 | +0.8% |
| Q3 2025 | $6.30 | +1.6% |
| Q2 2025 | $6.33 | +6.7% |
| Q1 2025 | $6.32 | +14% |
| Q4 2024 | $6.35 | +26% |
ROST's earnings per share have climbed steadily: $8.26 over the past year, up 31% from the year before, and higher year over year for 13 quarters in a row.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ROST on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
ROST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +13% |
| Q2 2026 | $6B | +21% |
| Q1 2026 | $6.6B | +12% |
| Q4 2025 | $5.6B | +10% |
| Q3 2025 | $5.5B | +4.6% |
| Q2 2025 | $5B | +2.6% |
| Q1 2025 | $5.9B | -1.8% |
| Q4 2024 | $5.1B | +3% |
ROST's revenue has grown year over year for six quarters in a row: $6.3B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +6.1 points |
| Q2 2026 | 13% | +1.2 points |
| Q1 2026 | 12% | -0.8 points |
| Q4 2025 | 12% | -1.2 points |
| Q3 2025 | 12% | -1.8 points |
| Q2 2025 | 12% | -0.9 points |
| Q1 2025 | 13% | -0.2 points |
| Q4 2024 | 13% | +0.7 points |
ROST has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ROST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $624.5M | +34% |
| Q2 2026 | $627.1M | +210% |
| Q1 2026 | $920.8M | +36% |
| Q4 2025 | $617.8M | +86% |
| Q3 2025 | $466.6M | +18% |
| Q2 2025 | $202.3M | -13% |
| Q1 2025 | $676.6M | -6.9% |
| Q4 2024 | $333M | +22% |
ROST has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ROST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1.8M shares |
| 1 year | -1.6% | -5.3M shares |
| 3 years | -5.5% | -18.5M shares |
| 5 years | -10% | -35.5M shares |
| Available history | -11% | -39.8M shares |
ROST has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $318.8M |
| Q2 2026 | $318.8M |
| Q1 2026 | $262.5M |
| Q4 2025 | $262.5M |
| Q3 2025 | $262.5M |
| Q2 2025 | $262.5M |
| Q1 2025 | $262.5M |
| Q4 2024 | $262.5M |
ROST spent $1.2B buying back its own shares over the past year, up 11% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ROST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
ROST has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ROST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 33.0 | Neutral |
ROST's weekly RSI is 56 (neutral) and its Stochastic is 33 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over ROST on valuation relative to its sector.
ROST PE vs Consumer Cyclical Sector
| Metric | ROST | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 59% above |
| PE % | 68 | 47 | 21 pts above |
ROST is trading at 29x earnings, a 59% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ROST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $231.2 | 2.6% above |
| 20 week MA | $233.3 | 1.7% above |
| 50 week MA | $218.3 | 8.7% above |
| 100 week MA | $181.3 | 31% above |
| 200 week MA | $155.3 | 53% above |
ROST is in an uptrend: it's above all five of its weekly moving averages, and 53% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
ROST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $115.0 | $118.0 | +2.7% |
| 2021 | $118.0 | $110.2 | -6.7% |
| 2022 | $110.2 | $115.5 | +4.8% |
| 2023 | $115.5 | $138.4 | +20% |
| 2024 | $138.4 | $153.0 | +11% |
| 2025 | $153.0 | $181.1 | +18% |
| 2026 YTD | $181.1 | $237.2 | +31% |
ROST has the edge over AMZN on returns for 2026, with the stronger performance.